What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “The Main Target Lesion will be marked by at least 3 ink marks prior to PDT to enable precise excision for histopathological assessment 12 weeks after the first or second PDT cycle dependent on the clearance status of the lesion. All target lesions should be prepared prior to drug application by degreasing, removal of all scabs and crusts, and roughening of the surface, if appropriate. Bleeding…”In the company’s words, NCT03573401 on ClinicalTrials.gov
- Tested for
- Superficial Basal Cell Carcinoma
- Main trialPhase 3
- “The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) with the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for superficial basal cell carcinoma (BCC).”In the company’s words, NCT03573401 on ClinicalTrials.gov
- Other names
- Ameluz
Other drugs for Superficial Basal Cell Carcinoma
- BO-112Highlight Therapeutics · Phase 2
- STAR0602Marengo Therapeutics, Inc. · Phase 1/2
- MDNA11Medicenna Therapeutics, Inc. · Phase 1/2
- PembrolizumabMerck & Co. · Phase 1/2
- Vusolimogene OderparepvecReplimune, Inc. · Phase 1/2
- CemiplimabRegeneron · Phase 2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 19 Mar 2024 | Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). | |
| Phase 3Completed | Sep 2014 | Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT) | |
| Phase 3Completed | 17 Nov 2015 | Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy | |
| Phase 3Completed | 3 Sep 2025 | Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp | |
| Phase 1Completed | 9 Sep 2020 | Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK) | |
| Phase 1Completed | 20 Apr 2023 | Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026